InsiderTrades.com logo
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

ICR Insider Trading

Insider Ownership Percentage: 56.85%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Intelicare Insider Trading History Chart

This chart shows the insider buying and selling history at Intelicare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intelicare Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/25/2021 01:00 PM ET

This chart shows the closing price history over time for ICR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Intelicare Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/5/2022Scott TaylorInsiderIssued1,900,000A$0.04A$68,400.00
9/9/2021Jason WallerInsiderBuy1,150,000A$0.12A$132,250.00
7/16/2021Jason WallerInsiderBuy28,000A$0.18A$5,040.00
6/23/2021Greg LeachInsiderIssued96,154A$0.26A$25,000.04
See Full Table
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Intelicare (ASX:ICR)

1.62% of Intelicare stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Intelicare Holdings Limited engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care and health industries in Australia. The company's smart home and predictive analytics platform combines discreet sensors, wearable technology, and alert devices to create layers of client intelligence and insights. It's hardware solutions comprise smart home sensors, emergency alerts, and vitals and health metrics devices. In addition, the company produces monitoring solution for seniors and at-risk individuals. Intelicare Holdings Limited was founded in 2016 and is based in Leederville, Australia.
Read More on Intelicare

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.45

Who are the company insiders with the largest holdings of Intelicare?

Intelicare's top insider shareholders include:
  1. Scott Taylor (Insider)
Learn More about top insider investors at Intelicare.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>